Who
Jeffrey K. cohen
Director
Company insider
Files Form 4 as: Director, Aspira Women's Health.
In numbers
- Trades disclosed
- 11
- Buys
- 2
- Sells
- 0
- Bought
- $75K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 9 May 2025
- Last trade
- 2 Dec 2025
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Dec 2025filed 3 Dec 2025 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code A | —213,518 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Bought | $25K55,556 at $0.45 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —41,667 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —41,667 at $0.00 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Bought | $25K55,556 at $0.45 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Code J | $5,00011,112 at $0.45 | filing |
| 17 Sep 2025filed 29 May 2026 | Aspira Women's Health | SEC FORM 4 Code J | $5,00011,112 at $0.45 | filing |
| 17 Sep 2025filed 19 Sep 2025 | Aspira Women's Healthoption or derivative | SEC FORM 4 Code P | —41,667 at $0.00 | filing |
| 17 Sep 2025filed 19 Sep 2025 | Aspira Women's Health | SEC FORM 4 Bought | $25K55,556 at $0.45 | filing |
| 13 May 2025filed 4 Jun 2025 | Aspira Women's Health | SEC FORM 4 Code A | $81611,653 at $0.07 | filing |
| 9 May 2025filed 4 Jun 2025 | Aspira Women's Health | SEC FORM 4 Code A | $3,09844,260 at $0.07 | filing |
News
No headline names them, or the companies they trade most, lately.